Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALL [Phase 2]
This is a Phase 2 clinical trial evaluating olverembatinib as maintenance or preemptive therapy after allogeneic hematopoietic stem cell tra…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse [Phase 2]
Phase 2 study evaluating ponatinib in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia, including MRD-positive and …
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL [Phase 2]
A Phase 2 clinical trial evaluating a chemotherapy-free combination of venetoclax, azacitidine, and orebatinib for newly diagnosed Philadelp…
-
CLINICAL_TRIALS research · 2018-07-30Clinical Trial Update: Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL
An update on a clinical trial evaluating tyrosine kinase inhibitors combined with low-intensity chemotherapy in Philadelphia chromosome-posi…
-
CLINICAL_TRIALS research · 2014-01-13Clinical Trial Update: Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)
Clinical trial update on the AMICA study examining patterns of ABL mutations in Asian patients with imatinib-resistant chronic myeloid leuke…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-10-19Clinical Trial Update: Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) [Phase 2]
This is a Phase 2 clinical trial update comparing imatinib with chemotherapy as induction therapy in elderly patients with Philadelphia chro…